/

News

FIECON keeping you updated: Insights, News, and Industry Developments

Explore the latest updates, thought leadership, and technological advancements from FIECON’s team, ensuring you stay informed about the evolving landscape of health economics and market access.

Meet ISPOR Poster Author : Laurence Tilley

Laurence Tilley - Senior Associate, HEOR and Access shares insights to his co-authored research poster "Cost-Effectiveness of Icosapent Ethyl in Patients with Recent Acute Coronary Syndrome in Catalonia," featured at ISPOR Europe 2024.

JCA updates: Balancing Act for Spanish HTA

How does the new Spanish HTA process reflect their attitude toward JCA regulation?

JCA update: FIECON experts keeping you in the loop about JCA.

Stay informed with our analysis of the latest JCA updates and their impact on healthcare policy.

JCA a Better Way: Understand JCA in one minute

Understand JCA in one minute

Key insights: Future Cancer Inquiry

Future Cancer: NICE Medicines Appraisal (Enhertu), HC 739 was discussed with the committee and representatives from Pharma about the changes by NICE in 2022 to assess the cost-effectiveness of drugs.

Learning insights: Blended Survival Analysis

Why do we need blended survival analysis and what are the benefits and challenges?

Learning Insights: Beyond Cost-Effectiveness

Apart from cost-effectiveness, what other factors should be considered when determining the likelihood of HTA success?

Key Insights: Advanced Therapies 2024

The Advanced Therapies Congress is Europe’s largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies.

Meet the experts: David Bryan

David Bryan, our Chief Financial Officer with a wealth of experience in financial management, talks about his journey to becoming our new CFO, his leadership style, and his expectations at FIECON.

Meet the experts: Lisa Cox

Lisa Cox, our in-house expert in HTA submissions and ultra-rare diseases discusses her strategic vision for the industry. She also explores upcoming trends in pharmaceuticals and elaborates on how FIECON is adapting to industry changes.

Times/LDC People First Award 2023

On 18th October FIECON CEOs, Mark and Kuntal Fisher won The Times/LDC People First Award.

Strategic Council expands expertise

FIECON is excited to announce a significant expansion of the expertise available to clients through the newly formed FIECON Strategic Council.

Partnership transformation

We stand at the threshold of a new era in evidence synthesis. FIECON has joined forces with Nested Knowledge, Inc., an industry leader in AI-based SaaS platform solutions. Together, we are on a transformative path, leveraging cutting-edge AI technology to revolutionise the Systematic Literature Review (SLR) and meta-analysis process.